NCT07370805Not yet recruiting
18F-FAPI PET in Lung Cancer
Prospective Clinical Study and Exploration of 18F-FAPI PET/CT Imaging in Lung Cancers
Source: ClinicalTrials.gov · Last updated 27 Jan 2026
Brief summary (registry, in English)
This study aims to evaluate the diagnostic efficacy and prognostic value of 18F-FAPI PET/CT in lung cancer.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 120 (estimated)
- First submitted
- 25 Dec 2025
- Start date
- 1 Feb 2026
- Primary completion date
- 31 Dec 2027
- Lead sponsor
- First Affiliated Hospital of Zhejiang University
- Diseases
- Lung cancer
- NCT number
- NCT07370805
What you commit to
- Study type: Observational
- Planned participants: 120
- From 1 Feb 2026 to the primary completion date, 31 Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent presence of other active malignant tumors or a history of other
Other illness
- malignant tumors within the past 5 years;
- Severe uncontrollable diseases or active infections;
Other
- Ineligible participants for project informed consent；
- Pregnant and lactating women.
Who the study is looking for
- Clinical diagnosis of Lung Cancer
- With 18F FAPI PET scan
Age in the registry: 20 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.